Wilk v. Purdue Pharma L.P., et al
Kevin Wilk |
Teva Pharmaceuticals USA, Inc., Janssen Pharmaceuticals, Inc., McKesson Corporation, Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., Purdue Pharma L.P., Actavis, Inc., AmeriSourceBergen Corporation, Johnson & Johnson, Cardinal Health, Inc., Watson Pharmaceuticals, Inc., INSYS Therapeutics, Inc., The Purdue Frederick Company, Inc., Purdue Pharma Inc., Teva Pharmaceutical Industries, Ltd., Actavis PLC, Cephalon, Inc. and Watson Laboratories, Inc. |
5:2018cv00517 |
October 30, 2018 |
US District Court for the Eastern District of North Carolina |
Terrence W Boyle |
Racketeer/Corrupt Organization |
28 U.S.C. ยง 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on November 27, 2018. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 6 CONDITIONAL TRANSFER ORDER (CTO-67) - This case is transferred under 28 U.S.C. 1407 to the Northern District of Ohio for the reasons stated in the order of December 5, 2017, and, with the consent of that court, assigned to the Honorable Dan A. Polster. Signed by Jeffery N. Luthi, Clerk of the United States Judicial Panel on Multidistrict Litigation. (Stay lifted on 11/27/2018.) (Stouch, L.) |
Case transferred to District of Northern Ohio. File transmitted electronically. (Stouch, L.) |
Remark - Case opened in Northern District of Ohio as case 1:18-op-46266, filed 11/27/2018. (Stouch, L.) |
Filing 5 Order Redesignating Division to Western Division. This case is redesignated as a Western Division case. The Honorable Terrence W. Boyle, Chief United States District Judge, will remain the presiding judge. All future documents shall reflect the new case number of 5:18-CV-517-BO. No further filing shall be made in 4: l 8-CV-181-BO. Signed by Peter A. Moore, Jr., Clerk of Court on 10/31/2018. (Stouch, L.) |
Notice to Counsel - This case should have been filed in the Western division. The Clerk will enter a reassignment order correcting the error. (Rudd, D.) |
Notice to Counsel - No Summons provided for issuance or Waiver of Service filed. (Rudd, D.) |
NOTICE OF CORRECTION regarding: Notice of Deficiency Failure to File Financial Disclosure, Notice to Counsel - Counsel has already filed the appropriate documents - The Financial Disclosure Statement has been filed at #2 and the Notices of Appearance have been filed at #3 and #4 . Please Disregard the Notice of Deficiency and the Notice to Counsel. (Rudd, D.) |
Notice to Counsel - All Counsel should file a Notice of Appearance pursuant to Local Civil Rule 5.2(a). (Rudd, D.) |
NOTICE OF DEFICIENCY - Failure to File Financial Disclosure Statement as to KEVIN WILK. Pursuant to 7.1 of the Federal Rules of Civil Procedure and Local Civil Rule 7.3, all parties shall file a financial disclosure statement. A negative statement is required if a party has no disclosures to make. The disclosure statement must be on a form provided by the clerk. This form is available at the clerk's office and on the court's website. (Rudd, D.) |
Filing 4 Notice of Appearance filed by James M. Hash on behalf of KEVIN WILK. (Hash, James) |
Filing 3 Notice of Appearance filed by E. D. Gaskins, Jr on behalf of KEVIN WILK. (Gaskins, E.) |
Filing 2 Financial Disclosure Statement by KEVIN WILK (Gaskins, E.) |
Filing 1 COMPLAINT against All Defendants ( Filing fee $ 400 receipt number 0417-4707714.), filed by KEVIN WILK. (Attachments: #1 Civil Cover Sheet) (Gaskins, E.) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.